ISCTR Symposium Monday, March 16, 2015 | San Diego Convention Center
2015 Symposium
Session I ISCTR Overview – Moderators Anthony DeMaria and Robert Roberts
10:45 – 10:50
Welcome Statement – Anthony DeMaria
10:50 – 11:00
Statement from CEO of ACC – Shal Jacobovitz
View Presentation
11:00 – 11:15
Overview of Cardiovascular Translational Research – Nabil Dib
View Presentation
Session II Cardiovascular Translational Research Pathway for Devices – Moderator Blasé Carabello
11:15 – 11:30
US Regulatory Pathway for Medical Devices – Bram Zuckerman
View Presentation
11:30 – 11:45
Large Animal Model for Heart Failure, Valvular Disease, Coronary Artery Disease, and Device Testing –
Daniel Burkhoff
View Presentation
11:45 – 12:00
Translational Pathway for Percutaneous Mitral Valve Repair/Replacement – Ted Feldman
View Presentation
12:00 – 12:15
Translational Pathway for Percutaneous Aortic Valve Replacement – Stan Rowe
View Presentation
Break
Continue Session II Cardiovascular Translational Research Pathway for Devices – Moderators Magdi Yacoub and Blasé
Carabello
12:30 – 12:45
Translational Pathway for BVA (Bio-absorbable Stent) – Patrick Serruys
View Presentation
12:45 – 1:00
Panel Discussion – Nabil Dib, Bram Zuckerman, Stan Rowe, Daniel Burkhoff, Ted Feldman, Patrick
Serruys, Richard Reposa
View Presentation
Session III Cardiovascular Translational Research Pathway for Biologics – Moderators Stefanie Dimmeler and Nabil
Dib
1:00 – 1:15
US Regulatory Requirement for Biologics – Speaker TBD
View Presentation
1:15 – 1:30
Animal Model of MI, CHF, and Coronary Ischemia for Biologic Evaluation – Steven Chamuleau
View Presentation
1:30 – 1:45
Methods of Delivery for Biologics – Nabil Dib
View Presentation
Break
Continue Session III Cardiovascular Translational Research Pathway for Biologics – Moderators Stefanie Dimmeler and
Nabil Dib
2:00 – 2:15
Translational Pathway for Cellular Therapy – Andreas Zeiher
View Presentation
2:15 – 2;30
Pre-Clinical and Clinical Imaging for Biologics Outcome – Didier Locca
View Presentation
2:30 – 2:45
Pathology Evaluation for Regenerative Therapy – Stefanie Dimmeler
View Presentation
2:45 – 2:55
Panel Discussion – Nabil Dib, Steven Chamuleau, Andreas Zeiher, Stefanie Dimmeler, Didier Locca
Session IV Cardiovascular Translational Pathways for Drugs – Moderators Robert Roberts and Hendrik Tevaerai
2:55 – 3:10
Cardiovascular Translational Pathways for Drugs – Hendrik Tevaearai
View Presentation
3:10 – 3:20
Personalized Medicine – Robert Roberts
View Presentation
3:20 – 3:30
Panel Discussion – Robert Roberts and Hendrik Tevaerai
Session V Translational Research Scholarship Curriculum and Educational Program – Moderators Spencer King and
Daniel Burkhoff
3:45 – 4:00
Status and Future Plans of the Overall ISCTR Educational Program and Curriculum – Spencer King
View Presentation
4:00 – 4:10
ISCTR Scholar Point of View – Zain Khalpey
View Presentation
4:10 – 4:15
Panel Discussion – Spencer King, Daniel Burkhoff, and Zain Khalpey
Session VI Opportunities for Translational Research and Unmet Needs for Industry Moderators Charles Simonton and
Mark Toland
4:15 – 4:25
Charles Simonton – Abbott Laboratories
4:25 – 4:35
Craig Stolen – Boston Scientific
View Presentation
4:45 – 4:55
Robert Thatcher – Cardiovascular Systems, Inc
4:55 – 5:05
Stanton Rowe – Edward’s Life Sciences
5:05 – 5:15
Panel Discussion – Charles Simonton, Craig Stolen, Mark Toland, Stanton Rowe